Rimstar Film-Coated Tablet
Out of date information, search anotherPACKAGE LEAFLET: INFORMATION FOR THE PATIENT xxxxxxxx
Voractiv® film-coated tablets
Rifampicin (150 mg) + Isoniazid (75 mg) + Pyrazinamide (400 mg) + Ethambutol hydrochloride (275 mg)
GENUS PHARMACEUTICALS
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (see section 4).
What is in this leaflet:
1. What Voractiv is and what it is used for
2. What you need to know before you take Voractiv
3. How to take Voractiv
4. Possible side effects
5. How to store Voractiv
6. Contents of the pack and other information
Voractiv belongs to a group of medicines called antituberculosis agents. It is a fixed combination of four very effective antituberculosis agents. It is used to treat infections caused by mycobacteria. These mycobacteria cause tuberculosis.
Voractiv is used for the initial treatment of tuberculosis.
Do not take Voractiv:
• if you are allergic (hypersensitive) to rifamycins, isoniazid, pyrazinamide, ethambutol hydrochloride or to any of the ingredients of this medicine (listed in section 6)
• if you have acute liver problems or previously have had a liver problem which was caused by drugs
• if you are known to have a condition called porphyria
• if you have acute gouty arthritis
• if you have severe kidney problems
• if you are currently taking any of the following medications:
- voriconazole
- protease inhibitors except ritonavir when prescribed to you at full dose or 600 mg twice daily.
Do not take Voractiv if any of the above apply to you.
If you are not sure about anything, ask your doctor or pharmacist.
Warnings and precautions
Talk to your doctor or pharmacist before taking Voractiv.
Tell your doctor if you have one of the following illnesses before taking this medicine:
• Liver problems and chronic liver disease
• Kidney problems
• Gout
• Diabetes mellitus
• Epilepsy
• Inflammation of peripheral nerves or the optic nerve
• Eye defects
• Chronic alcoholism
• Underfeeding.
You should not take Voractiv if your body weight is below 30 kg.
You should not interrupt treatment with Voractiv without consulting your doctor.
You should employ additional means of contraception apart from taking the pill as long as you take Voractiv.
Other medicines and Voractiv:
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including any medicines obtained without a prescription.
Tell your doctor if you take one of the following medicines:
You must not take Voractiv with any of the following medications:
• voriconazole
• protease inhibitors except ritonavir if you are prescribed a full dose or 600 mg twice daily.
You should not take Voractiv with any of the following medications:
• nevirapine
• simvastatin
• ritonavir
• oral contraceptives. You should use additional means of contraception as long as you take Voractiv.
Tell your doctor also if you take one of the following medicines:
• Medicines for irregular heart beats like class Ia antiarrhythmics (quinidine, disopyramide), propafenone, mexiletine, tocainide, lorcainide
• Medicines for the heart or blood pressure: calcium antagonists (such as diltiazem, nifedipine, verapamil, nimodipine, isradipine, nicardipine, nisoldipine), digitoxin, digoxin, carvedilol, digoxin, beta-blockers (such as bisoprolol, metoprolol, propranolol, carvedilol), losartan, imidapril, enalapril
• Diuretics like eplerenone
• Medicines to suppress the immune system like ciclosporin, tacrolimus, sirolimus, leflunomide, azathioprine
• Corticosteroids
• Medicines to treat fungal infections
(antifungals like fluconazole, itraconazole, ketoconazole, voriconazole, terbinafine)
• Antibiotics like clarithromycin, telithromycin, dapsone, doxycycline, fluoroquinolones, chloramphenicol, linezolid
• Medicines to treat malaria: atovaquone, quinine
• Medicines for your mood like haloperidol, clozapine, aripiprazole, tricyclic antidepressants (like amitriptyline, nortriptyline)
• Medicines to prevent blood clots like oral anticoagulants, warfarin
• Hormone treatments like antioestrogens (such as gestrinone, tamoxifene, toremifene) oestrogens and progestagens given as hormonal replacement therapy or contraceptives, thyroid hormones (levothyroxine)
• Medicines for pain like morphine etoricoxib, rofecoxib
• Medicines for AIDS like saquinavir, indinavir, efavirenz, amprenavir, nilfinavir, azatanavir, lopinavir, zidovudine, nevirapine, stavudine
• Medicines for epilepsy like tiagabine, carbamazepine, phenytoine, ethosuximide
• Medicines for sleeping disorders like diazepam, benzodiazepines, buspirone, zopiclone, zolpidem, zaleplon, hexobarbital
• Medicines for asthma like theophylline
• Medicines for diabetes like repaglinide and nateglinide or oral antidiabetics of sulfonylurea type
• p-aminosalicylic acid (a medicine for tuberculosis and inflammatory bowel diseases)
• Methadone (a medicine for heroin addicts)
• Medicines for stomach problems like cimetidine
• Medicines for the treatment of high blood lipids like cloifibrate, fluvastatin, simvastatin
• Medicines for sickness like tropisetron, ondansetron
• Medicines for narcosis like halogenated volatile anesthetics
• Medicines to treat cancer like imatinib, gefitinib, irinotecan
• Fexofenadine (a medicine to treat hayfever)
• Praziquantel (a medicine against tapeworms)
• Oral typhoid vaccine
If you are currently taking any of these medicines, ask your doctor about switching to a different medicine while you are taking Voractiv. Often, there are other medicines you can take instead.
If you need to take a medicine for indigestion, such as an antacid, take your tablets at least one hour before the antacid.
The following examination methods cannot be performed or results have to be interpreted with care as long as you take Voractiv:
• radiographic examination of the gallbladder with contrast media
• microbiological determination of folic acid plasma concentrations
• microbiological determination of cyanocobalamin (vitamin B12) plasma concentrations.
Voractiv with food and drink:
Do not drink any alcohol as long as you receive Voractiv.
You should avoid food with a high content of tyramine (like cheese, red wine) or histamine (like tuna fish). This food taken together with Voractiv may lead to headache, palpitations or flushing.
Take this medicine at least one hour before a meal.
Pregnancy and breast-feeding:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Your doctor will assess whether it is possible for you to continue with the treatment of Voractiv. If you take Voractiv during pregnancy, your doctor should give you vitamin B6 supplements during pregnancy and vitamin K supplements during the last month of pregnancy.
This medicine goes into human milk, therefore you should not take Voractiv when you are breast-feeding. It is important that you tell your doctor if you are breast-feeding or if you intend to breast-feed before receiving Voractiv.
Driving and using machines:
This medicine can cause side effects such as dizziness, confusion and blurred vision. This may make you less able to do certain things, such as driving or using machines.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. These doses are for adults and children weighing more than 30 kg. Children weighing less than this should not take these tablets.
The recommended dose is:
Adults:
The amount of Voractiv people take can be different, and this depends on your body weight. Usually, you will be given the following number of tablets:
• If you weigh 30 kilograms (kg) to 39 kg -
take 2 tablets each day
• If you weigh 40 kg to 54 kg - take 3 tablets each day
• If you weigh 55 kg to 70 kg - take 4 tablets each day
• If you weigh more than 70 kg - take 5 tablets each day.
Your doctor will prescribe the best dose for you.
25290301
GEN/VCT/PIL/317_01
Use in children
Voractiv is not recommended for children under 8 years of age or with a body weight of less than 30 kg.
Older people
Voractiv is well tolerated by most older patients, but you should inform your doctor if you are suffering from liver or kidney disease. In some cases your doctor may recommend that you take additional vitamin B6 as long as you take Voractiv.
Method of administration
You should take Voractiv once a day during the first two months of treatment.
Swallow these tablets whole with a drink of water.
Voractiv should be taken at least 1 hour before a meal.
Duration of treatment:
Voractiv is usually given for 2 months at the beginning of tuberculosis treatment. Your doctor will decide on the duration of treatment for you.
If you take more Voractiv than you should:
If you accidentally take one tablet too many, nothing is likely to happen. If you accidentally take several tablets too many, contact your doctor or talk to your nearest hospital casualty department immediately. If possible, take your tablets or the box with you to show the doctor what you have taken.
If you forget to take Voractiv:
If you forget to take a dose, take it as soon as possible. However, if it is nearly time for your next dose skip the missed dose and take the next tablet at the usual time.
If you stop taking Voractiv:
Always keep taking the tablets until the course is finished, even if you feel better. If you stop taking the tablets too soon, the infection may come back. Also, the bacteria may become resistant to the medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
corticosteroid hormones), induction of crisis in Addison’s patients (patients with a special form of hormonal disorder)
• Psychosis, hyperactivity, euphoria, sleeplessness, convulsions
• Muscular weakness, myopathy, problems with the coordination of voluntary muscles (ataxia), increase in seizure frequency in epileptics
• Disturbances of vision, damage to the optic nerve
• Numbness, tingling, burning pain or weakness in hands or feet
• Gastritis, jaundice, enlargement of the liver, inflammation of the liver (in rare cases severe)
• Allergic and other reactions like dry mouth, heartburn, urination disorders, rheumatic syndromes and symptoms, pellagra (characterized by gastrointestinal disturbances, reddening of skin, nervous and mental disorders), swelling of lymph nodes, acne, skin rash, light sensitivity
• Elevation of kidney enzymes, acute kidney failure, inflammation of the kidney, problems with urination
• Induction of a condition called porphyria (a group of disorders characterized by light-sensitivity, skin lesions, anaemia, psychosis and acute abdominal pain).
If you resume therapy after an interruption of treatment with Voractiv, a so-called influenzalike syndrome may occur.
It is characterized by fever, shivering and possibly headache, dizziness, bone and muscle pain. In rare cases bleeding into the skin, breathing difficulties, asthma-like attacks, anaemia, shock and kidney failure might develop.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Serious side effects:
If you have any of the following symptoms of a severe allergic reaction stop taking this medicine and tell your doctor immediately or go to the casualty department at your nearest hospital:
• Sudden difficulty in breathing, speaking and swallowing
• Swelling of lips, tongue, face or neck
• Extreme dizziness or collapse
• Severe or itchy skin rashes, especially if this shows blistering and there is soreness of the eyes, mouth or genital organs.
If you experience any of the following side effects contact your doctor as soon as possible:
• Diarrhoea that is serious, lasts a long time or has blood in it with stomach pain or fever: This can be a sign of serious bowel inflammation
• Bleeding into the skin; if you continue taking Voractiv, you are at risk of brain haemorrhage (bleeding)
• Yellowing of the skin or whites of the eyes, or urine getting darker and stools paler, fatigue, weakness, malaise, loss of appetite, nausea or vomiting caused by liver problems (hepatitis)
• Inflammation of the pancreas, which causes severe pain in the abdomen and back (pancreatitis)
• Vision disturbances like blurred vision, eye pain, red-green colour blindness or even loss of vision
• Shortage of white blood cells, accompanied by sudden high fever, severe sore throat and ulcers in the mouth (agranulocytosis).
These are all serious side effects. You may need urgent medical attention. Serious side effects are rare (may affect up to 1 in 1,000 people) or very rare (may affect up to 1 in 10,000 people).
Other side effects:
Common side effects (may affect up to 1 in 10 people):
• Tiredness, drowsiness, headache, lightheadedness, dizziness
• Damage of peripheral nerves
• Reddening of the eyes, permanent discoloration of soft contact lenses
• Nausea, vomiting, loss of appetite, abdominal pain, bloatedness, epigastric distress
• Flushing, itching with or without skin rash, nettle rash
• Allergic or other reactions like skin rash, fever, muscle or joint pain
• Increase of liver enzymes
• Disturbances of liver function which might show as loss of appetite, nausea, vomiting, fatigue, malaise and weakness
• Reddish discoloration of body fluids and secretions like urine, tear fluid, sweat, sputum, stools and saliva
• Increase in blood uric acid, acute gouty arthritis (chills, pain and swelling of joints, especially big toe, ankle or knee).
Uncommon side effects (may affect up to 1 in 100 people):
• Hallucinations, disorientation, confusion, malaise.
Rare side effects (may affect up to 1 in 1,000 patients):
• Changes of white and red blood cell count, changes of platelet count, anaemia, disorders of blood clotting, swelling of spleen
• Oedema/swelling because of water retention
• Diarrhoea
• Menstrual disturbances, swelling of breast tissue in men, early puberty, difficulties in diabetes control, high blood sugar, Cushing’s syndrome (disease caused by increase of
Keep out of the sight and reach of children.
Do not use Voractiv after the expiry date which is stated on the carton, label, or blister after EXP. The expiry date refers to the last day of that month.
Do not store above 30°C.
Blisters: Store in the original package in order to protect from moisture.
Containers: Keep the container tightly closed in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Voractiv contains
The active substances are rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride. Each tablet contains 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide and 275 mg ethambutol hydrochloride.
- The other excipients are Tablet core:
Pregelatinised maize starch, Maize starch, Sodium laurilsulfate, Microcrystalline cellulose, Povidone K 30, Crospovidone, Magnesium stearate, Talc.
Film-coating:
Copovidone, Hypromellose, Talc, Titanium dioxide (E171), Opadry brown 03B56510 [hypromellose, titanium dioxide (E171), macrogol 400, red iron oxide (E172)], Opadry clear OY-S-29019 [hypromellose, macrogol 6000].
What Voractiv looks like and contents of the pack
Voractiv, film-coated tablets are brown, ovaloid, biconvex film-coated tablets.
Voractiv, film-coated tablets may be packed in the following pack sizes:
Carton box with blisters containing:
30, 60,120, 240, 672 or 1000 film-coated tablets.
White, opaque polypropylene container with polyethylene cap containing: 500 film-coated tablets.
White, opaque polyethylene container with polypropylene cap containing: 500 film-coated tablets.
Pack sizes of 500 and 1000 film-coated tablets are intended for clinical use. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Sandoz Ltd., Frimley Business Park,
Frimley, Camberley, Surrey GU16 7SR. Manufacturer:
Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Austria or
Sandoz S.R.L., Str.Livezeni nr. 7a, RO-540472, Targu-Mures, Romania
Distributed by:
Genus Pharmaceuticals,
Linthwaite, Huddersfield, HD7 5QH, UK.
This leaflet was last revised in December 2014.
’Trademark
25290301 GENUS PHARMACEUTICALS
GEN/VCT/PIL/317_01
09/12/2014